Treatment Intensification With Temozolomide in Adults With a Glioblastoma (StrateGlio)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03663725

Recruitment Status : Recruiting

First Posted : September 10, 2018

Last Update Posted : May 15, 2019

See Contacts and Locations

Sponsor:

Collaborators:

Association de Neuro-Oncologues d'Expression Francaise

Erasme University Hospital

Information provided by (Responsible Party):

Centre Oscar Lambret

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Recruiting
Estimated Primary Completion Date :	May 1, 2022
Estimated Study Completion Date :	May 1, 2023

To Top